Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.

Branch AD, Van Natta ML, Vachon ML, Dieterich DT, Meinert CL, Jabs DA; Studies of the Ocular Complications of AIDS Research Group..

Clin Infect Dis. 2012 Jul;55(1):137-44. doi: 10.1093/cid/cis404.

2.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord..

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005.

PMID:
23583272
3.

Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study.

Omland LH, Krarup H, Jepsen P, Georgsen J, Harritshøj LH, Riisom K, Jacobsen SE, Schouenborg P, Christensen PB, Sørensen HT, Obel N; DANVIR Cohort Study..

J Hepatol. 2010 Jul;53(1):36-42. doi: 10.1016/j.jhep.2010.01.033.

PMID:
20400197
4.

Comparison of deaths related to Hepatitis C and AIDS in Scotland.

Palmateer NE, Hutchinson SJ, McLeod A, Codere G, Goldberg DJ.

J Viral Hepat. 2007 Dec;14(12):870-4.

PMID:
18070290
5.

Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.

van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Chêne G, Dorrucci M, Muga R, Porter K, Prins M; CASCADE Collaboration in EuroCoord..

Gastroenterology. 2013 Apr;144(4):751-760.e2. doi: 10.1053/j.gastro.2012.12.026.

PMID:
23266560
6.

Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems.

Fuster D, Cheng DM, Quinn EK, Nunes D, Saitz R, Samet JH, Tsui JI.

Addiction. 2014 Jan;109(1):62-70. doi: 10.1111/add.12367.

7.

Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.

Clausen LN, Weis N, Schønning K, Fenger M, Krarup H, Bukh J, Benfield T.

Scand J Infect Dis. 2011 Oct;43(10):798-803. doi: 10.3109/00365548.2011.589077.

PMID:
21728744
8.

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.

Mussini C, Lorenzini P, Puoti M, Lichtner M, Lapadula G, Di Giambenedetto S, Antinori A, Madeddu G, Cozzi-Lepri A, d'Arminio Monforte A, De Luca A; ICONA Foundation Study Group..

PLoS One. 2015 Dec 7;10(12):e0140877. doi: 10.1371/journal.pone.0140877.

9.

Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.

van Griensven J, Phirum L, Choun K, Thai S, De Weggheleire A, Lynen L.

PLoS One. 2014 Feb 12;9(2):e88552. doi: 10.1371/journal.pone.0088552.

11.

Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy.

Grint D, Peters L, Reekie J, Soriano V, Kirk O, Knysz B, Suetnov O, Lazzarin A, Ledergerber B, Rockstroh JK, Mocroft A; EuroSIDA in EuroCoord (European Coordinating Committee for the Integration of Ongoing Coordination Actions Related to Clinical and Epidemiological HIV Research)..

HIV Med. 2013 Jul;14(6):370-8. doi: 10.1111/hiv.12033.

12.

Hepatitis C and progression of HIV disease.

Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL.

JAMA. 2002 Jul 10;288(2):199-206.

PMID:
12095384
13.

Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study.

SMART Study Group., Peters L, Neuhaus J, Mocroft A, Soriano V, Rockstroh J, Dore G, Puoti M, Tedaldi E, Clotet B, Kupfer B, Lundgren JD, Klein MB.

Antivir Ther. 2011;16(5):667-75. doi: 10.3851/IMP1815.

14.

Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy.

Raboud J, Anema A, Su D, Klein MB, Zakaryan A, Swan T, Palmer A, Hosein S, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg RS, Cooper C; Canadian Observational Cohort (CANOC) Collaboration..

HIV Clin Trials. 2012 Mar-Apr;13(2):90-102. doi: 10.1310/hct1302-90.

PMID:
22510356
15.

Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis.

Medrano J, Álvaro-Meca A, Boyer A, Jiménez-Sousa MA, Resino S.

Crit Care. 2014 Aug 27;18(4):475. doi: 10.1186/s13054-014-0475-3.

16.

Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.

Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, Gatell J, d'Arminio Monforte A, Phillips A, Lundgren JD, Kirk O; EuroSIDA study group..

AIDS. 2012 Jan 28;26(3):315-23. doi: 10.1097/QAD.0b013e32834e8805.

PMID:
22112597
17.

Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.

Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL.

Clin Infect Dis. 2005 Mar 15;40(6):859-67.

18.

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J; EuroSIDA Study Group..

J Infect Dis. 2005 Sep 15;192(6):992-1002.

19.

Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.

Vispo E, Barreiro P, Plaza Z, Fernández-Montero JV, Labarga P, de Mendoza C, Sierra-Enguita R, Treviño A, Lopez M, Soriano V.

AIDS. 2014 Jun 19;28(10):1473-8. doi: 10.1097/QAD.0000000000000275.

PMID:
24637541
20.

Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.

Than NN, Sungkanuparph S, Maek-A-Nantawat W, Kaewkungwal J, Pitisuttithum P.

Southeast Asian J Trop Med Public Health. 2012 May;43(3):646-51.

PMID:
23077844
Items per page

Supplemental Content

Support Center